NCT05768867

Brief Summary

This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

March 6, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2023

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

March 3, 2023

Last Update Submit

August 26, 2024

Conditions

Peyronie Disease

Outcome Measures

Primary Outcomes (1)

  • Rate of responses

    Response rate to the online questionnaire.

    Day 0

Interventions

FRAnçaise du PEYronie's Disease QUESTionnaireOTHER

Complete an online FRAnçaise du PEYronie's Disease QUESTionnaire

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Peyronie's Disease

You may qualify if:

  • Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque

You may not qualify if:

  • Patient refusing to participate
  • Patient with difficulties in understanding the French language.
  • Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toulouse Hospital

Toulouse, France

Location

MeSH Terms

Conditions

Penile Induration

Condition Hierarchy (Ancestors)

Penile DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Eric Huyghe, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2023

First Posted

March 14, 2023

Study Start

March 6, 2023

Primary Completion

May 22, 2023

Study Completion

May 22, 2023

Last Updated

August 27, 2024

Record last verified: 2024-08

Locations

FR(1)